| P50 | author | Nicole J Horwood | Q58888477 |
| P2093 | author name string | Nicole J Horwood | |
| P2860 | cites work | T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ | Q59064307 |
| | Prostaglandin E2 signals through PTGER2 to regulate sclerostin expression | Q21560844 |
| | Commitment to the B-lymphoid lineage depends on the transcription factor Pax5 | Q22010683 |
| | IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis | Q24563235 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells | Q24627585 |
| | Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice | Q24642117 |
| | Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis | Q28118730 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells | Q28591227 |
| | Osteoblastic cells regulate the haematopoietic stem cell niche | Q29615007 |
| | Identification of the haematopoietic stem cell niche and control of the niche size | Q29615008 |
| | Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches | Q29617460 |
| | Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 |
| | Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro | Q33814310 |
| | Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis | Q34059280 |
| | Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo | Q34153374 |
| | T-lymphocytes enable osteoblast maturation via IL-17F during the early phase of fracture repair | Q34328599 |
| | Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation | Q34339627 |
| | Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. | Q34412527 |
| | DAP12 overexpression induces osteopenia and impaired early hematopoiesis | Q34775668 |
| | Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide | Q34829342 |
| | Risk of vertebral fracture in women with rheumatoid arthritis | Q35187252 |
| | IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation | Q35219971 |
| | Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism | Q35367510 |
| | Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization | Q35441456 |
| | Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis | Q35534758 |
| | B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo | Q35804512 |
| | Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow | Q35826041 |
| | Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells | Q35849312 |
| | Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH | Q35849800 |
| | Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells. | Q36100425 |
| | Regulation of bone biology by prostaglandin endoperoxide H synthases (PGHS): a rose by any other name... | Q36388212 |
| | Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size | Q36403763 |
| | Osteoclasts, rheumatoid arthritis, and osteoimmunology | Q36501073 |
| | Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injury. | Q36632775 |
| | Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches | Q36691868 |
| | Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning. | Q36962694 |
| | The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell | Q36979047 |
| | COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing | Q37172205 |
| | In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. | Q37414697 |
| | The HSC niche concept has turned 31. Has our knowledge matured? | Q37730874 |
| | The endosteal 'osteoblastic' niche and its role in hematopoietic stem cell homing and mobilization | Q37791426 |
| | New regulation mechanisms of osteoclast differentiation | Q37987556 |
| | Tec family kinases in inflammation and disease | Q37997073 |
| | New developments in osteoimmunology | Q38052462 |
| | Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity | Q38071110 |
| | B-cell targeted therapeutics in clinical development | Q38097162 |
| | Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells | Q38506162 |
| | Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone | Q39116021 |
| | Prostaglandin E2 receptor EP4-selective agonist (ONO-4819) increases bone formation by modulating mesenchymal cell differentiation | Q39305262 |
| | Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells | Q40277201 |
| | Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells. | Q40285802 |
| | A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation | Q40498732 |
| | Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes | Q40626937 |
| | Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. | Q40756953 |
| | B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta | Q40875461 |
| | CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance | Q43226905 |
| | Monokines produced by macrophages stimulate the growth of osteoblasts | Q43947297 |
| | Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo | Q46277067 |
| | Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling | Q46291802 |
| | Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model | Q46294640 |
| | Effect of prostaglandin E2 on mineralization of bone nodules formed by fetal rat calvarial cells | Q46295011 |
| | Absence of B cells does not compromise intramembranous bone formation during healing in a tibial injury model. | Q46369480 |
| | Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats | Q46721318 |
| | Interferon-γ plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. | Q51506098 |
| | Regulatory T cells protect from local and systemic bone destruction in arthritis. | Q53294686 |
| | Ovariectomy-induced bone loss occurs independently of B cells. | Q53510692 |
| | Strontium can increase some osteoblasts without increasing hematopoietic stem cells. | Q53519157 |
| | Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. | Q54041247 |
| | IFN-gamma enhances osteoclast generation in cultures of peripheral blood from osteopetrotic patients and normalizes superoxide production. | Q54042043 |
| | Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. | Q54415335 |
| | β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice | Q57116531 |
| P433 | issue | 7 | |
| P304 | page(s) | 532-543 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Immunological Investigations | Q15754982 |
| P1476 | title | Immune cells and bone: coupling goes both ways | |
| P478 | volume | 42 | |